153 related articles for article (PubMed ID: 38051513)
1. Neuroendocrine tumors' patients treated with somatostatin analogue could complicate with emergency cholecystectomy.
Calomino N; Poto GE; Carbone L; Bagnacci G; Piccioni S; Andreucci E; Nenci L; Marano L; Verre L; Petrioli R; Roviello F; Marrelli D
Ann Ital Chir; 2023; 94():518-522. PubMed ID: 38051513
[TBL] [Abstract][Full Text] [Related]
2. Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study.
Brighi N; Lamberti G; Maggio I; Manuzzi L; Ricci C; Casadei R; Santini D; Mosconi C; Lisotti A; Ambrosini V; Pantaleo MA; Campana D
Dig Liver Dis; 2019 May; 51(5):689-694. PubMed ID: 30314949
[TBL] [Abstract][Full Text] [Related]
3. Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.
Brighi N; Panzuto F; Modica R; Gelsomino F; Albertelli M; Pusceddu S; Massironi S; Lamberti G; Rinzivillo M; Faggiano A; Spallanzani A; Ferone D; Prinzi N; Rossi RE; Annibale B; Colao AM; Campana D
Oncologist; 2020 Mar; 25(3):259-265. PubMed ID: 32162819
[TBL] [Abstract][Full Text] [Related]
4. Cholelithiasis and cholecystitis.
Schirmer BD; Winters KL; Edlich RF
J Long Term Eff Med Implants; 2005; 15(3):329-38. PubMed ID: 16022643
[TBL] [Abstract][Full Text] [Related]
5. Small gallstones are associated with increased risk of acute pancreatitis: potential benefits of prophylactic cholecystectomy?
Venneman NG; Buskens E; Besselink MG; Stads S; Go PM; Bosscha K; van Berge-Henegouwen GP; van Erpecum KJ
Am J Gastroenterol; 2005 Nov; 100(11):2540-50. PubMed ID: 16279912
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic cholecystectomy in midgut carcinoid patients.
Norlén O; Hessman O; Stålberg P; Akerström G; Hellman P
World J Surg; 2010 Jun; 34(6):1361-7. PubMed ID: 20130865
[TBL] [Abstract][Full Text] [Related]
7. Port site metastases a year after initial laparoscopic cholecystectomy. Should the use of retrieval bags during laparoscopic cholecystectomy be the new gold standard?
Petryshyn N; Dražić T; Hogendorf P; Strzelczyk J; Strzałka A; Szwedziak K; Durczyński A
Pol Przegl Chir; 2021 May; 93(6):61-65. PubMed ID: 36169533
[TBL] [Abstract][Full Text] [Related]
8. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours].
Uomo G; Germano D; Rabitti PG
Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting mortality in patients over 70 years of age submitted to surgery for gallbladder or common bile duct stones.
Burdiles P; Csendes A; Diaz JC; Maluenda F; Avila S; Jorquera P; Aldunate M
Hepatogastroenterology; 1989 Jun; 36(3):136-9. PubMed ID: 2753458
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up study of gallbladder in situ after endoscopic common duct stone removal in Korean patients.
Cui ML; Cho JH; Kim TN
Surg Endosc; 2013 May; 27(5):1711-6. PubMed ID: 23242488
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.
Stueven AK; Kayser A; Wetz C; Amthauer H; Wree A; Tacke F; Wiedenmann B; Roderburg C; Jann H
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234481
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Tumour of the Gallbladder Diagnosed after Cholecystectomy.
Tasci HI; Coskunoglu EZ; Turk E; Karagulle E
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S127-S129. PubMed ID: 36210670
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacologic therapy for neuroendocrine tumours].
Petrányi A; Bodoky G
Orv Hetil; 2011 Mar; 152(10):379-91. PubMed ID: 21354954
[TBL] [Abstract][Full Text] [Related]
14. Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy.
Ros E; Navarro S; Bru C; Garcia-Pugés A; Valderrama R
Gastroenterology; 1991 Dec; 101(6):1701-9. PubMed ID: 1955135
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules.
Massironi S; Conte D; Rossi RE
Scand J Gastroenterol; 2016; 51(5):513-23. PubMed ID: 26605828
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors.
Delaunoit T; Rubin J; Neczyporenko F; Erlichman C; Hobday TJ
Mayo Clin Proc; 2005 Apr; 80(4):502-6. PubMed ID: 15819288
[TBL] [Abstract][Full Text] [Related]
17. Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study.
Qureshi SA; Burch N; Druce M; Hattersley JG; Khan S; Gopalakrishnan K; Darby C; Wong JL; Davies L; Fletcher S; Shatwell W; Sothi S; Randeva HS; Dimitriadis GK; Weickert MO
BMJ Open; 2016 May; 6(5):e010765. PubMed ID: 27147385
[TBL] [Abstract][Full Text] [Related]
18. Increased Incidence of Symptomatic Cholelithiasis After Bariatric Roux-En-Y Gastric Bypass and Previous Bariatric Surgery: a Single Center Experience.
Sneineh MA; Harel L; Elnasasra A; Razin H; Rotmensh A; Moscovici S; Kais H; Shirin H
Obes Surg; 2020 Mar; 30(3):846-850. PubMed ID: 31901127
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of exocrine pancreatic insufficiency in patients with advanced neuroendocrine tumors treated with somatostatin analogs.
Rinzivillo M; De Felice I; Magi L; Annibale B; Panzuto F
Pancreatology; 2020 Jul; 20(5):875-879. PubMed ID: 32684368
[TBL] [Abstract][Full Text] [Related]
20. Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review.
Chan DL; Ferone D; Albertelli M; Pavlakis N; Segelov E; Singh S
Endocrine; 2017 Sep; 57(3):366-375. PubMed ID: 28726183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
